Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,730 | 539 | 98.9% |
| Education | $60.80 | 7 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $741.53 | 33 | $0 (2024) |
| PFIZER INC. | $634.72 | 80 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $591.16 | 64 | $0 (2019) |
| Amgen Inc. | $570.48 | 47 | $0 (2024) |
| Lilly USA, LLC | $560.84 | 56 | $0 (2024) |
| Novo Nordisk Inc | $519.56 | 47 | $0 (2024) |
| Merck Sharp & Dohme LLC | $331.03 | 50 | $0 (2022) |
| Allergan, Inc. | $304.26 | 37 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $291.70 | 30 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $178.36 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $251.55 | 14 | ABBVIE INC. ($65.27) |
| 2023 | $281.21 | 17 | Novo Nordisk Inc ($43.30) |
| 2022 | $130.54 | 9 | Novartis Pharmaceuticals Corporation ($31.06) |
| 2020 | $300.33 | 17 | AstraZeneca Pharmaceuticals LP ($60.20) |
| 2019 | $1,255 | 135 | PFIZER INC. ($200.48) |
| 2018 | $1,716 | 162 | AstraZeneca Pharmaceuticals LP ($293.44) |
| 2017 | $1,856 | 192 | AstraZeneca Pharmaceuticals LP ($296.33) |
All Payment Transactions
546 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Obesity | ||||||
| 08/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Insomnia | ||||||
| 05/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Bone Health | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Respiratory | ||||||
| 04/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 03/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.33 | General |
| Category: Cardiovascular | ||||||
| 03/04/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Central Nervous System | ||||||
| 02/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Inflammation | ||||||
| 02/20/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Vaccines | ||||||
| 12/06/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Cardio-renal | ||||||
| 12/05/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Diabetes | ||||||
| 11/08/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 10/05/2023 | SANOFI PASTEUR INC. | VAXELIS (Biological), MENQUADFI, BEYFORTUS | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Vaccines | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: INSOMNIA | ||||||
| 09/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Obesity | ||||||
| 08/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/01/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 706 | 972 | $282,525 | $78,340 |
| 2022 | 10 | 813 | 1,177 | $287,017 | $84,789 |
| 2021 | 9 | 785 | 1,241 | $279,693 | $85,911 |
| 2020 | 10 | 736 | 1,260 | $258,851 | $71,632 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 221 | 378 | $121,954 | $35,519 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 216 | 216 | $90,072 | $25,901 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 165 | 260 | $58,058 | $15,359 | 26.5% |
| 69210 | Removal of impacted ear wax | Facility | 2023 | 22 | 33 | $5,743 | $585.81 | 10.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 13 | $1,842 | $490.10 | 26.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Facility | 2023 | 29 | 29 | $1,675 | $247.95 | 14.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 41 | 43 | $3,182 | $237.51 | 7.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 195 | 352 | $108,145 | $34,775 | 32.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 216 | 216 | $85,752 | $26,513 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 202 | 321 | $68,219 | $18,287 | 26.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Facility | 2022 | 12 | 12 | $3,114 | $1,508 | 48.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 18 | 18 | $2,503 | $828.67 | 33.1% |
| 93793 | Anticoagulant management of patient taking warfarin | Facility | 2022 | 20 | 98 | $4,226 | $735.88 | 17.4% |
| 69210 | Removal of impacted ear wax | Facility | 2022 | 37 | 44 | $7,284 | $711.03 | 9.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 11 | 11 | $1,344 | $676.11 | 50.3% |
| G0444 | Annual depression screening, 15 minutes | Facility | 2022 | 60 | 60 | $3,280 | $522.78 | 15.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 42 | 45 | $3,150 | $231.99 | 7.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 270 | 530 | $106,880 | $33,026 | 30.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 234 | 234 | $88,200 | $29,311 | 33.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 101 | 161 | $46,970 | $16,125 | 34.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2021 | 14 | 14 | $7,939 | $2,232 | 28.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Facility | 2021 | 16 | 17 | $7,427 | $1,777 | 23.9% |
| 69210 | Removal of impact ear wax, one ear | Facility | 2021 | 56 | 67 | $10,530 | $1,308 | 12.4% |
| 93793 | Anti-clotting management for patient taking warfarin | Facility | 2021 | 27 | 145 | $5,883 | $1,121 | 19.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 16 | $2,051 | $680.08 | 33.2% |
About Dr. Michelle Craig, D.O
Dr. Michelle Craig, D.O is a Family Medicine healthcare provider based in Waterloo, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1568698389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Craig, D.O has received a total of $5,790 in payments from pharmaceutical and medical device companies, with $251.55 received in 2024. These payments were reported across 546 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,730).
As a Medicare-enrolled provider, Craig has provided services to 3,040 Medicare beneficiaries, totaling 4,650 services with total Medicare billing of $320,673. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Waterloo, IA
- Active Since 06/08/2009
- Last Updated 09/13/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1568698389
Products in Payments
- FARXIGA (Drug) $560.38
- XARELTO (Drug) $392.96
- TRULICITY (Drug) $378.59
- CHANTIX (Drug) $369.35
- Prolia (Biological) $246.80
- JARDIANCE (Drug) $208.84
- JANUVIA (Drug) $197.97
- INVOKANA (Drug) $192.18
- Saxenda (Drug) $163.28
- PREVNAR - 13 (Biological) $151.38
- Trintellix (Drug) $146.83
- BEVESPI AEROSPHERE (Drug) $144.73
- Aimovig (Biological) $136.81
- ENTRESTO (Drug) $134.04
- Victoza (Drug) $118.83
- VRAYLAR (Drug) $108.23
- EVENITY (Biological) $105.09
- LINZESS (Drug) $99.57
- ELIQUIS (Drug) $73.29
- Trulance (Drug) $68.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Waterloo
Nicholas Goetsch, D.o, D.O
Family Medicine — Payments: $660,696
Matthew Smith, Md, MD
Family Medicine — Payments: $28,135
Dr. Gregory Harter, Md, MD
Family Medicine — Payments: $15,682
Dr. Andrew Reese, Md, MD
Family Medicine — Payments: $9,797
Robert Pranger, Md, MD
Family Medicine — Payments: $4,801
Dr. Jay Pickett, Md, MD
Family Medicine — Payments: $2,607